Focus Forward: The Tipping Point

Posted 01 February 2011 | By

A few weeks ago, I attended a conference addressing the changing nature of the bio/pharmaceutical sectors, and particularly challenges in the regulatory approaches and the interface with reimbursement and economic factors.While the meeting focused most heavily on challenges in the US, many speakers and attendees emphasized that those same issues are shared around the world. Many at this meeting believed we are on the brink of major changes in the healthcare product sector.

Categories:

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe